RT Journal Article
SR Electronic
T1 COVID-19 self-testing in Nigeria: Stakeholders’ opinions and perspective on its value for case detection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.28.22269743
DO 10.1101/2022.01.28.22269743
A1 Undelikwo, Veronica A.
A1 Shilton, Sonjelle
A1 Folayan, Morenike Oluwatoyin
A1 Alaba, Oluwatoyin
A1 Reipold, Elena Ivanova
A1 Martínez-Pérez, Guillermo Z.
YR 2022
UL http://medrxiv.org/content/early/2022/01/29/2022.01.28.22269743.abstract
AB Background COVID-19 testing coverage is limited in Nigeria. Access to SARS-CoV-2 self-testing kits may help improve the detection of asymptomatic and mildly symptomatic cases and increase the currently low rate of COVID-19 testing in the country. Before implementing SARS-CoV-2 self-testing in Nigeria, it is imperative to assess the populations’ perceptions regarding this innovation. We therefore conducted a qualitative study to investigate people’s values and preferences for SARS-CoV-2 self-testing in Nigeria.Methods We used semi-structured interviews and focus group discussions among healthcare workers, community representatives, and public health implementors to explore values and perceptions around various aspects of COVID-19 testing, including conventional COVID-19 testing, SARS-CoV-2 self-testing, the safe and effective use of SARS-CoV-2 self-testing, actions upon receiving a positive SARS-CoV-2 self-test result, and future prospects for SARS-CoV-2 self-testing.Results Respondents reported that there is limited availability of conventional SARS-CoV-2 testing in Nigeria. While just a few respondents were familiar with SARS-CoV-2 testing, respondents generally supported the use of SARS-CoV-2 self-testing as they felt it could assist with early case detection and improve access to testing. Concerns relating to the use of SARS-CoV-2 self-testing were majorly about the ability among low literacy populations to use and interpret the test, the affordability of tests, equity of access, and the availability of healthcare system support for those who test positive.Conclusion Though the public perceive multiple benefits associated with access to SARS-CoV-2 self-testing, the efficiency of the national health service delivery system may limit access of the users of the kits to psychosocial and clinical support. In Nigeria, where COVID-19 vaccine coverage is low and the risk of further waves of COVID-19 is high, self-testing may assist in the prompt detection of cases and contribute to halting the spread of the virus.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Government of Germany. The funders played no role in the study design; in the collection, management, analysis, or interpretation of the data; in writing the report; or in the decision to submit the report for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received ethics approval from the Health Research Ethics Committee of the Obafemi Awolowo University in Ile-Ife (Ref. IPH/OAU/12/1730).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available.